Literature DB >> 10649442

Human angiogenin is rapidly translocated to the nucleus of human umbilical vein endothelial cells and binds to DNA.

G f Hu1, C j Xu, J F Riordan.   

Abstract

Human angiogenin is translocated to the nucleus of human umbilical vein endothelial cells in a time-dependent manner. Exogenous angiogenin appears in the nucleus in 2 min, reaches saturation in 15 min when 85% of the internalized angiogenin is in the nuclei, and remains associated with the nucleus for at least 4 h. Endothelial cells cultured at low density have a much higher capacity to translocate angiogenin to the nucleus than do those cultured at high density. This observation is consistent with previous findings that both the ability of endothelial cells to proliferate in response to angiogenin and the expression of an angiogenin receptor on the cell surface depend on cell density. Nuclear (125)I-angiogenin is not degraded and is neither spontaneously dissociated nor replaced by unlabeled angiogenin. It is, however, released by deoxyribonuclease I, but not by ribonuclease A, suggesting that angiogenin binds to DNA in the nucleus. These results suggest that in addition to acting as a ribonuclease, angiogenin may play a role in regulating gene expression by direct binding to DNA. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10649442     DOI: 10.1002/(sici)1097-4644(20000301)76:3<452::aid-jcb12>3.0.co;2-z

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  31 in total

1.  A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation.

Authors:  Norie Yoshioka; Li Wang; Koji Kishimoto; Takanori Tsuji; Guo-fu Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-13       Impact factor: 11.205

2.  Angiogenin stimulates ribosomal RNA transcription by epigenetic activation of the ribosomal DNA promoter.

Authors:  Jinghao Sheng; Wenhao Yu; Xiangwei Gao; Zhengping Xu; Guo-Fu Hu
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

3.  Angiogenin as a molecular target for the treatment of prostate cancer.

Authors:  Shuping Li; Soichiro Ibaragi; Guo-Fu Hu
Journal:  Curr Cancer Ther Rev       Date:  2011-05

Review 4.  New insights into the role of angiogenin in actin polymerization.

Authors:  Mikhail G Pyatibratov; Alla S Kostyukova
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

5.  Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.

Authors:  Sathish Sadagopan; Mohanan Valiya Veettil; Nitika Paudel; Virginie Bottero; Bala Chandran
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

6.  G-quadruplex structures contribute to the neuroprotective effects of angiogenin-induced tRNA fragments.

Authors:  Pavel Ivanov; Elizabeth O'Day; Mohamed M Emara; Gerhard Wagner; Judy Lieberman; Paul Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

7.  Neamine induces neuroprotection after acute ischemic stroke in type one diabetic rats.

Authors:  R Ning; M Chopp; A Zacharek; T Yan; C Zhang; C Roberts; M Lu; J Chen
Journal:  Neuroscience       Date:  2013-11-08       Impact factor: 3.590

Review 8.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

9.  Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription.

Authors:  Soichiro Ibaragi; Norie Yoshioka; Shuping Li; Miaofen G Hu; Saori Hirukawa; Peter M Sadow; Guo-Fu Hu
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

10.  Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis.

Authors:  Rubén Fernández-Santiago; Sabine Hoenig; Peter Lichtner; Anne-Dorte Sperfeld; Manu Sharma; Daniela Berg; Oliver Weichenrieder; Thomas Illig; Katharina Eger; Thomas Meyer; Johanna Anneser; Christoph Münch; Stephan Zierz; Thomas Gasser; Albert Ludolph
Journal:  J Neurol       Date:  2009-04-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.